ICH Q9(R1): Guidelines on Pharmaceutical Risk Management

Delivery Mode: Webinar

An introduction to the ICH Q9(R1): Guidelines on Pharmaceutical Risk Management. This lesson covers the fundamentals for assessing and mitigating risks during drug product lifecycles and incorporates the latest requirements from ICH Q9(R1), which was updated in 2023, and supports and sets the foundation for a safety and quality-centric approach. By integrating with other ICH standards, it sets the foundation for a safety and quality-centric approach.

CEUs are provided once you achieve an 80% passing grade and complete the evaluation.

The course is self-paced. On average, the time required for completion ranges from 1 to 3 hours.

Included in the Regulatory CMC Essentials Certificate Program

 
The Regulatory CMC Essentials Certificate is a comprehensive, competency-based training program designed to build foundational expertise in global pharmaceutical quality and Chemistry, Manufacturing, and Controls (CMC) regulation. Centered on the International Council for Harmonisation (ICH) Q6–Q10 and Q12 guidelines, this certificate provides learners with the critical, foundational knowledge required to navigate quality expectations across the product lifecycle including using the science and risk-based approach—from development and manufacturing to change management and continual improvement. Learn More and Register

Registration Fee

MemberNonmember
US$270US$300   

Buy Now Return to Online Learning